Solidion Technology Q4 2025 Earnings Continued Losses Amidst No Revenue DPRO Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Stock Gains on Optimism Around Operational Progress Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain GRBK Q1 2026 Earnings EPS Surges 15 Above Estimates NEN Q4 2024 Earnings Partnership Reports 3612 EPS Amid Limited Disclosure BTMD Q1 2026 Earnings EPS Beats Estimates by 2371 Amid Revenue Discrepancy